China’s Original Innovative Drug Cipepofol Approved for Marketing by the U.S. FDA

BEIJING, June 1, 2026 /PRNewswire/ — Cipepofol (CYPSEDO) Injection (hereinafter “Cipepofol”), a Class 1 innovative intravenous anesthetic independently developed by Haisco Pharmaceutical Group, has officially received marketing approval from the U.S....